Status:
UNKNOWN
Post-interventional Future for Adolescents From the PRALIMAP-INÉS Trial
Lead Sponsor:
Central Hospital, Nancy, France
Collaborating Sponsors:
University of Lorraine
Cnam-ISTNA
Conditions:
Overweight and Obesity
Eligibility:
All Genders
18+ years
Brief Summary
The research focuses on a follow-up measure of participants in the PRALIMAP-INÈS cohort (NCT01688453 - Legrand et al. 2017). PRALIMAP-INÈS was conducted between 2012 and 2015 with the objective of sho...
Detailed Description
Beforehand, an information letter will be sent to the young adults included in PRALIMAP-INÈS at the postal and e-mail addresses initially provided. The objective is to present the study and to inform ...
Eligibility Criteria
Inclusion
- As part of the cohort follow-up, all young adults who participated in the PRALIMAP-INÈS trial will be contacted again. Each young adult: Was enrolled in 3rd or 2nd grade in 2012, 2013 or 2014 in the participating schools in the PRALIMAP-INÈS program (T3: over 18 years old). years old)
- Participated in the PRALIMAP-INÈS trial, and thus was considered eligible for this trial trial (with a BMI above the IOTF threshold (Cole et al. 2000) of reduced overweight of 1 kg/m² for age and sex and/or an abdominal circumference greater than the McCarthy McCarthy cut-offs for age and sex (McCarthy, Jarrett, and Crawley 2001) and having received a medical interview)
- Is enrolled in or receiving social security benefits
Exclusion
- As part of the cohort follow-up, there are no non-inclusion criteria.
Key Trial Info
Start Date :
December 13 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
852 Patients enrolled
Trial Details
Trial ID
NCT05386017
Start Date
December 13 2022
End Date
June 30 2024
Last Update
October 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU de Nancy
Nancy, France, 54000